Literature DB >> 28127119

Repeat ablation and hospitalization following cryoballoon ablation of atrial fibrillation at a single tertiary medical center.

Cara East1, Teresa Phan1, Giovanni Filardo1, Jay Franklin1, Alan Donsky1, Kevin R Wheelan1, Robert C Kowal1.   

Abstract

Cryoablation for atrial fibrillation (AF) has rapidly become a mainstream treatment for AF. In this report, 163 patients who had undergone a cryoablation procedure at one clinical center were contacted by telephone 33.1 ± 3.3 months after the procedure. All patients had received cryoablation of the pulmonary vein ostia, although concomitant procedures were performed at the same time in over 50% of the patients, including radiofrequency and/or cryoablation of other areas of the left atrium. Freedom from a repeat ablation procedure was 87%, while freedom from recurrent hospitalization for AF was 89%, as compared to previous reports of 65%. Of the 13 patients who had a repeat ablation procedure, only one was found to have a reconnection of pulmonary veins, while 4 were found to have atrial flutter. Cryoablation for AF produces a durable result in most patients out to 3 years with better outcomes than previously reported.

Entities:  

Year:  2017        PMID: 28127119      PMCID: PMC5242100          DOI: 10.1080/08998280.2017.11929511

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  19 in total

1.  Long-term comparison of cryoballoon and radiofrequency ablation of paroxysmal atrial fibrillation: a propensity score matched analysis.

Authors:  Sven Knecht; Christian Sticherling; Stefanie von Felten; David Conen; Beat Schaer; Peter Ammann; David Altmann; Stefan Osswald; Michael Kühne
Journal:  Int J Cardiol       Date:  2014-07-02       Impact factor: 4.164

2.  Cryoballoon versus radiofrequency catheter ablation for paroxysmal atrial fibrillation.

Authors:  Jeremiah Wasserlauf; Daniel J Pelchovitz; John Rhyner; Nishant Verma; Martha Bohn; Zhi Li; Rishi Arora; Alexandru B Chicos; Jeffrey J Goldberger; Susan S Kim; Albert C Lin; Bradley P Knight; Rod S Passman
Journal:  Pacing Clin Electrophysiol       Date:  2015-01-28       Impact factor: 1.976

3.  Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.

Authors:  Jason G Andrade; Paul Khairy; Laurent Macle; Doug L Packer; John W Lehmann; Richard G Holcomb; Jeremy N Ruskin; Marc Dubuc
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-01-19

4.  The long-term efficacy of cryoballoon vs irrigated radiofrequency ablation for the treatment of atrial fibrillation: A meta-analysis.

Authors:  Xiaocheng Cheng; Qiongwen Hu; Changyue Zhou; Lin Qiong Liu; Tong Chen; Zengzhang Liu; Xuewen Tang
Journal:  Int J Cardiol       Date:  2014-12-03       Impact factor: 4.164

5.  Acute and Long-Term Outcomes of Catheter Ablation of Atrial Fibrillation Using the Second-Generation Cryoballoon versus Open-Irrigated Radiofrequency: A Multicenter Experience.

Authors:  Arash Aryana; Sheldon M Singh; Marcin Kowalski; Deep K Pujara; Andrew I Cohen; Steve K Singh; Ryan G Aleong; Rajesh S Banker; Charles E Fuenzalida; Nelson A Prager; Mark R Bowers; André D'Avila; Padraig Gearoid O'Neill
Journal:  J Cardiovasc Electrophysiol       Date:  2015-06-04

6.  Durability of Pulmonary Vein Isolation with Cryoballoon Ablation: Results from the Sustained PV Isolation with Arctic Front Advance (SUPIR) Study.

Authors:  Vivek Y Reddy; Lucie Sediva; Jan Petru; Jan Skoda; Milan Chovanec; Zita Chitovova; Paola Di Stefano; Ethel Rubin; Srinivas Dukkipati; Petr Neuzil
Journal:  J Cardiovasc Electrophysiol       Date:  2015-04-15

7.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.

Authors:  Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

8.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

Authors:  David J Wilber; Carlo Pappone; Petr Neuzil; Angelo De Paola; Frank Marchlinski; Andrea Natale; Laurent Macle; Emile G Daoud; Hugh Calkins; Burr Hall; Vivek Reddy; Giuseppe Augello; Matthew R Reynolds; Chandan Vinekar; Christine Y Liu; Scott M Berry; Donald A Berry
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272

9.  First-line catheter ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation.

Authors:  Florian Straube; Uwe Dorwarth; Sonia Ammar-Busch; Timo Peter; Georg Noelker; Thomas Massa; Malte Kuniss; Niels Christian Ewertsen; Kyoung Ryul Julian Chun; Juergen Tebbenjohanns; Roland Tilz; Karl Heinz Kuck; Taoufik Ouarrak; Jochen Senges; Ellen Hoffmann
Journal:  Europace       Date:  2015-10-25       Impact factor: 5.214

10.  Cryoballoon Versus Open Irrigated Radiofrequency Ablation in Patients With Paroxysmal Atrial Fibrillation: The Prospective, Randomized, Controlled, Noninferiority FreezeAF Study.

Authors:  Armin Luik; Andrea Radzewitz; Meinhard Kieser; Marlene Walter; Peter Bramlage; Patrick Hörmann; Kerstin Schmidt; Nicolas Horn; Maria Brinkmeier-Theofanopoulou; Kevin Kunzmann; Tobias Riexinger; Gerhard Schymik; Matthias Merkel; Claus Schmitt
Journal:  Circulation       Date:  2015-08-17       Impact factor: 29.690

View more
  1 in total

1.  Characterization of atrial flutter after pulmonary vein isolation by cryoballoon ablation.

Authors:  Jayson R Baman; Rachel M Kaplan; Celso L Diaz; Graham Peigh; Aakash A Bavishi; Amar Trivedi; Jeremiah Wasserlauf; Alexandru B Chicos; Rishi Arora; Susan Kim; Albert Lin; Nishant Verma; Bradley P Knight; Rod S Passman
Journal:  J Interv Card Electrophysiol       Date:  2019-05-17       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.